EDUCATION 1. Ph.D 1982, University of Athens, Athens, Greece, Biochemistry, Mentor Professor Dr. Constantine Sekeris. 2. M.Sc 1972, University of Bucharest, School of Chemistry, Bucharest, Romania,Biochemistry.Mentor Associate Professor Dr. Ion F. Dumitru. POSTDOCTORAL TRAINING 1.”Visiting” Scientist, Department of Immunology, U.T.M. D. Anderson Cancer Center, Anderson,Houston, Texas 77030, (“M. D. Anderson”), Mentor: Dr. Chris D. Platsoucas, 9/1985 - 9/1987. (“Visiting Scientist” for J-1 Visa is Post-Doctoral Fellow, with >3 years post PhD experience from Foreign Countries) 2.”Visiting” Scientist, Department of Microbiology, Mt. Sinai School of Medicine, New York, 10029, Mentor: Dr. Constantin A. Bona, 4/1985 - 9/1985. 3.Assistant Professor of Research, Department of Immunology, Hellenic Anticancer Institute, Athens, Greece, Mentor: Dr. Michael Papamichail, 9/1981 - 3/1985. (Official title: 3rd Researcher salary & Rank Asst Professor). ACADEMIC APPOINTMENTS 1991-2010. Assisted with Greek and Romanian Language and referral of foreign patents. 1.Chemist I and Chemist II, Department of Bacterial Biochemistry, Cantacuzino Institute for Immunology, Microbiology and Vaccines, Bucharest, Romania. (“Cantacuzino Institute”), 1972 − 1975. 2. Assistant Director,Culture Media Laboratory,Cantacuzino Institute, 1972-1975. 3.Chemist-III, (highest rank) Department of Virology, Cantacuzino Institute, 1975 − 1978 4. Research Assistant, Department of Immunology, Hellenic Anticancer Institute, 10/78 − 8/81, 5. Assistant Immunologist and Assistant Professor of Immunology (Gynecology), Department of Gynecologic Oncology, (“Gyn-Oncol)”, MDAnderson,77030,10/87 − 8/93. 7. Associate Immunologist and Associate Professor of Immunology Gyn-Oncol, MD Anderson, 1993 − 1999. 8. Assistant Director, Immunology and Molecular Biology, Gyn-Oncol, MD. Anderson, 1988 – 1995. 9. Professor of Immunology, Gyn-Oncol, MD Anderson, 9/2000-8/31/2008. 10. Professor, Experimental Therapeutics, MD Anderson, 9/2008-1/2010. 11. Director,Immunology &Vaccine Research Laboratory,Gyn-Oncol. MD Anderson 1998 – 2010. Saved > $ 87,000.00 in administrative costs to MDAnderson, 5/20/2005-8/31/2008. 12. Member, University of Texas Health Science Center, Graduate School of Biomedical Sciences, Houston 13. Affiliated Member, The Center of Minority Health. 14.Terminated. Leave as Principal and only Caretaker, 2/1/2010-5/10/2011,now private profession. DURABLE DISCOVERIES AND FEDERALY FUNDED -INVENTIONS PATENTED 1. USP 8,258,261 9/4/2012.Divisional.Induction of tumor immunity by variants of folate binding protein Ioannides CG, Peoples, Jr.; George E, Kathleen Ann (Newton, MA) Assignee HJF 2. USP 7,547,759, 6/16/2009. Cancer immunity by variants of folate binding protein. Ioannides CG and Peoples, GE Assignee UT System Board of Regents (Board) 3. USP 7,348,153, 3/25/2008. Novel melanoma peptide-vaccines derived from the high molecular weight proteoglycan antigen. Ferrone S, Ioannides CG, Kawano, K, Murray, JL. Assignee Board. 4. USP’ 6,514,942, 2/4/2003. Methods and compositions for stimulating T-lymphocytes.Ioannides CG, Bryan Fisk B and Ioannides, MG. Assignee Board 5. USP 5,434,076 7,1995. Human ovarian tumor-specific monoclonal antibodies. R.S. Freedman, C. G. Ioannides, R. Patenia, and B. Tomasovic. Assignee Board. 6. USPA: 10/507,009 Pending. Controlled modulation of immunogenicity by amino acid side length. Ioannides CG O’Brian CA, Campbell M, Peoples GE. Assignee Board. PATENT APPLICATIONS TO BE REVIVED 7. USPA 12,529,759 Submitted 3/09/2009. Cancer therapy by Notch and Numb tumor antigens. Ioannides CG, Matsueda S ,Mine T, Li Yufeng. Assignee: Board. 8.USPA 12,262,402 Submitted 01/05/2010. Mosaic helper peptides. Ioannides CG, Murray JL, Peoples GE, Efferson C, Kawano K, Tsuda N, Matsueda S, Li Yufeng. Assignee: Board INVENTIONS CLOSED, (INACTIVE), DUE TO FIRING 2010 9. Cancer Therapy by designed micro-RNA. Tsuda N, Kawano K, Chang DZ, Ioannides CG. 2007. 10. Priming of Th1 help and modulation by cytokines with opposed effects for cancer vaccination. Murray, JL, Kuerer H, O'Brian CA. and Ioannides, CG,2001. 11. Short pyknons in human RNA as anticancer agents. Li Y, Ioannides, CG. MDACC 09-094.2009. EXTERNAL FUNDS: $ 4,091,298.10 in 23 years, (1992-2015), not adjusted for inflation.